(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FATE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FATE

ST13

US500000086870141

Class

5, 42

Filing

86870141

Registration

5991392

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

05/02/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

01/08/2016

Registration date

02/18/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/01/2026

Last transaction

05/02/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/20/2016

First use in commerce

09/20/2016

Drawing code

3

Owner type

03

Owner location

San Diego, CA, US

Examiner

LAVACHE, LINDA M

Current location

Historical data usage

Mark description

The mark consists of the word "Fate" with the letter "a" including two small square elements in the lower right quadrant.

Holders and representatives

Holders

Fate Therapeutics, Inc.

Representatives

Jared M. Barrett Seed IP Law Group LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and therapeutic agents to modulate cell function or cell fate; reagents for clinical medical and medical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer and immune disorders; pharmaceutical and therapeutic agents for use as immunotherapies

Class 42

Medical and clinical research and development for others in the field of stem cells; consulting services in the field of stem cell therapy researchdisease model systems researchdrug discovery and development; medical laboratory research; researchscientific research; medical and scientific researchconducting pre-clinical and clinical trials

Publications

History of USPTO decisions and trademark events.

50 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/01/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/01/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/01/2026

E815

TEAS SECTION 8 & 15 RECEIVED

02/06/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/16/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/15/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/09/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/09/2020

ALIE

ASSIGNED TO LIE

01/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/17/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/19/2019

GNRT

NON-FINAL ACTION E-MAILED

06/19/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

06/19/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/16/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/15/2019

IUAF

USE AMENDMENT FILED

06/05/2019

EISU

TEAS STATEMENT OF USE RECEIVED

06/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/09/2019

EX4G

SOU EXTENSION 4 GRANTED

01/07/2019

EXT4

SOU EXTENSION 4 FILED

01/07/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/07/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/11/2018

EX3G

SOU EXTENSION 3 GRANTED

07/09/2018

EXT3

SOU EXTENSION 3 FILED

07/09/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/09/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/12/2018

EX2G

SOU EXTENSION 2 GRANTED

01/10/2018

EXT2

SOU EXTENSION 2 FILED

01/10/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/10/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/14/2017

EX1G

SOU EXTENSION 1 GRANTED

06/12/2017

EXT1

SOU EXTENSION 1 FILED

06/12/2017

EEXT

SOU TEAS EXTENSION RECEIVED

06/12/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/10/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/15/2016

PUBO

PUBLISHED FOR OPPOSITION

11/15/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/26/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/29/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/28/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/28/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/26/2016

GNRT

NON-FINAL ACTION E-MAILED

04/26/2016

CNRT

NON-FINAL ACTION WRITTEN

04/26/2016

DOCK

ASSIGNED TO EXAMINER

04/25/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/16/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/15/2016

NWAP

NEW APPLICATION ENTERED

01/12/2016

Continuous trademark protection

Get notified about every new filing that threatens FATE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.